Trxade Group (MEDS) delivers annual revenue growth of 130%

Trxade Q4 2020 earnings

Trxade (NASDAQ: MEDS) on Monday posted a 17% increase in fourth-quarter revenues to $2 million, riding on the strength of the Trxade

Trxade Q4 2020 earnings

Trxade Group (MEDS) delivers annual revenue growth of 130%

Trxade (NASDAQ: MEDS) on Monday posted a 17% increase in fourth-quarter revenues to $2 million, riding on the strength of the Trxade Platform and Trxade Prime. The top-line, however, missed the average Wall Street consensus.  Meanwhile, the company posted a

Viewing Highlight
Loading...
Highlight
Close
Top